bioAffinity Technologies (BIAFW) FCF Margin (2022 - 2026)
bioAffinity Technologies (BIAFW) reported FCF Margin of 239.2% for Q1 2026, down 14789.0% year-over-year from N/an in Q1 2025, and down 48.86% quarter-over-quarter from 160.69% in Q4 2025.
bioAffinity Technologies (BIAFW) FCF Margin (2022 - 2026) Analysis & Trends
bioAffinity Technologies (BIAFW) has 5 years of FCF Margin data on file, last reported at 239.2% in Q1 2026.
- FCF Margin for Q1 2026 came in at 239.2%, down 14789.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 193.11% (down 11763.0% YoY), and the FY2025 annual result was 152.38%, down 7393.0% from the prior year.
- FCF Margin slipped to 239.2% in Q1 2026 per BIAFW's latest filing, from 160.69% in the prior quarter.
- Over five years, FCF Margin peaked at 65.09% in Q2 2024 and troughed at 169528.23% in Q1 2023.
- A 5-year average of 25968.94% and a median of 190.43% in 2025 frame the typical range for FCF Margin.
- The sharpest annual moves came in 2024 and 2026: FCF Margin jumped 16942902 bps in 2024, then plunged 14789 bps in 2026.
- A 5-year view of FCF Margin shows it stood at 55440.58% in 2022, then surged by 100 bps to 72.42% in 2023, then decreased by 5 bps to 75.97% in 2024, then slumped by 112 bps to 160.69% in 2025, then tumbled by 49 bps to 239.2% in 2026.
- Business Quant data shows BIAFW's FCF Margin at 239.2% in Q1 2026, 160.69% in Q4 2025, and 171.27% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | -3.31% |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 7.41% |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 18.23% |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 22.61% |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 10.95% |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | 2.59% |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | 11.83% |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 23.01% |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | 12.92% |
| 10 | bioAffinity Technologies | - | - | - | -239.20% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -239.20% |
| Dec 31, 2025 | -160.69% |
| Sep 30, 2025 | -171.27% |
| Jun 30, 2025 | -209.58% |
| Mar 31, 2025 | -91.31% |
| Dec 31, 2024 | -75.97% |
| Sep 30, 2024 | -73.12% |
| Jun 30, 2024 | -65.09% |
| Mar 31, 2024 | -99.21% |
| Dec 31, 2023 | -72.42% |
| Sep 30, 2023 | -513.49% |
| Jun 30, 2023 | -6,909.57% |
| Mar 31, 2023 | -169,528.23% |
| Dec 31, 2022 | -55,440.58% |
| Sep 30, 2022 | -153,052.26% |
| Jun 30, 2022 | -28,801.00% |